Evaluation of pharmacokinetic drug-drug interaction between tegoprazan and clarithromycin in healthy subjects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of pharmacokinetic drug-drug interaction between tegoprazan and clarithromycin in healthy subjects

Published:2023 Issue:2 Volume:31 Page:114
ISSN:2289-0882
Container-title:Translational and Clinical Pharmacology
language:en
Short-container-title:Transl Clin Pharmacol

Author:

Oh Minkyung¹^ORCID,Lee Heechan²^ORCID,Kim Seokuee²^ORCID,Kim Bongtae²^ORCID,Song Geun Seog²^ORCID,Shin Jae-Gook¹³^ORCID,Ghim Jong-Lyul³^ORCID

Affiliation:

1. Department of Pharmacology and Clinical Pharmacology, Pharmcogenomics Research Center, Inje University College of Medicine, Busan 47392, Korea.

2. Division of Clinical Development, HK Inno.N Corp., Seoul 04551, Korea.

3. Department of Clinical Pharmacology, Inje University Busan Paik Hospital, Busan 47392, Korea.

Funder

HK inno.N Corp.

Publisher

XMLink

Subject

Pharmacology (medical)

Link

https://tcpharm.org/pdf/10.12793/tcp.2023.31.e11

Reference15 articles.

1. Update on the Management of Helicobacter pylori Infection

2. Review – Treatment of Helicobacter pylori infection 2020

3. The appropriate cutoff gastric pH value for Helicobacter pylori eradication with bismuth‐based quadruple therapy

4. Evidence that the Degree and Duration of Acid Suppression are Related to Helicobacter pylori Eradication by Triple Therapy

5. Randomised clinical trial: safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple oral doses of tegoprazan (CJ-12420), a novel potassium-competitive acid blocker, in healthy male subjects

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments;Current Gastroenterology Reports;2024-08-15

2. Pharmacokinetic Interactions Between Tegoprazan and the Combination of Clarithromycin, Amoxicillin and Bismuth in Healthy Chinese Subjects: An Open-Label, Single-Center, Multiple-Dosage, Self-Controlled, Phase I Trial;Clinical Drug Investigation;2024-04-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3